Traws Pharma

TRAWNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$7.684 M

$0.50 +0.04%

Close of 22 Sept 2026

Revenue

$2.79M

#3381 by revenue

Earnings

$9.17M

#2058 by earnings

Shares outstanding

15,368,277

Latest filing cover page

P/E ratio

0.8

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#444SoligenixSNGX$8.38M
#445Ensysce BiosciencesENSC$8.35M
#446Traws PharmaTRAW$7.68M
#447CNS PharmaceuticalsCNSP$7.66M
#448InMed PharmaceuticalsINM$7.64M

What if Traws Pharma were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,967,297

Per share 3,934,594× higher

Bitcoin $1.74T

$113,327.92

Per share 226,656× higher

Nvidia $5.52T

$358,905.99

Per share 717,812× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Traws Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.